ID   NCC-PLPS2-C1
AC   CVCL_C5Z1
DR   Wikidata; Q116049881
RX   PubMed=36436139;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 24 hours (PubMed=36436139).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Unspecified (PubMed=36436139).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Glu44Gly (c.131A>G); ClinVar=VCV000041768; Zygosity=Unspecified (PubMed=36436139).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>A); ClinVar=VCV001453627; Zygosity=Unspecified (PubMed=36436139).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foot, hypodermis; UBERON=UBERON_0002387+UBERON_0002072.
ST   Source(s): PubMed=36436139
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9
ST   D21S11: 29,30
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3705; Pleomorphic liposarcoma
DI   ORDO; Orphanet_99969; Pleomorphic liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
RX   PubMed=36436139; DOI=10.1007/s13577-022-00828-9;
RA   Akiyama T., Yoshimatsu Y., Noguchi R., Sin Y., Osaki J., Adachi Y.,
RA   Ono T., Tsuchiya R., Sato C., Iwata S., Kojima N., Yoshida A.,
RA   Ohtori S., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-PLPS2-C1: a novel cell line
RT   of pleomorphic liposarcoma.";
RL   Hum. Cell 36:468-475(2023).
//